Histologic criteria to distinguish low and high risk colorectal polyps

Histologic criteria distinguishing low-risk from high-risk colorectal polyps primarily focus on pathological features that predict potential for lymph node metastasis and recurrence risk following endoscopic resection. Key histologic high-risk features include lymphovascular invasion (LVI), poor histological differentiation, deep submucosal invasion, tumor budding, and positive or indeterminate resection margins. These features are consistently recognized across major international guidelines and underpin decisions regarding additional surgical intervention after endoscopic polypectomy or resection NHS Bowel polyps,NICE CKS,Lim and Sohn DK. 2026.

Lymphovascular invasion (LVI) is a strong marker of nodal involvement risk and generally warrants classification as high risk, indicating the need for additional surgery due to a significant increase in metastatic potential Lim and Sohn DK. 2026.

Poor histological differentiation (high-grade or grade ≥3) similarly signifies aggressive tumor biology, and polyps exhibiting this are categorized as high risk, prompting further treatment consideration Lim and Sohn DK. 2026.

Depth of submucosal invasion is critical in T1 colorectal cancers and malignant polyps, with deeper invasion (commonly ≥1,000 μm or sm2–sm3 level) associated with elevated lymph node metastasis risk. Some guidelines, notably Japanese and Korean, apply granular invasion depth categories to stratify risk, where deeper invasion increases risk and often merits surgery. Western guidelines may incorporate depth in cumulative risk models rather than as a binary cutoff Lim and Sohn DK. 2026.

Tumor budding, defined as isolated single cells or small clusters at the invasive front, is graded based on the number of buds per defined field; higher grades (BD2 and BD3) correlate with an increased risk of lymph node metastases and are included among high-risk features in guidelines, although its utilization varies by region Lim and Sohn DK. 2026.

Resection margin status, particularly positive or indeterminate vertical margins, indicates incomplete excision and a high risk of residual disease, thus classified within high-risk pathology necessitating further clinical action Lim and Sohn DK. 2026.

In addition to these five core features, morphological characteristics such as polyp size (≥10 mm), histological subtype (villous or tubulovillous components), and grade of dysplasia are significant. Advanced adenomas are typically defined as those ≥10 mm in size, or exhibiting villous/tubulovillous histology, or containing high-grade dysplasia, and are considered high-risk because of their increased malignant potential NHS Bowel polyps,Akimoto et al. 2026.

Histological classification also distinguishes serrated lesions into hyperplastic polyps, sessile serrated lesions (SSLs) with or without dysplasia, and traditional serrated adenomas (TSAs). Serrated lesions with dysplasia, including high-grade dysplasia, have a higher risk profile compared to non-dysplastic hyperplastic polyps and require closer surveillance Baker et al. 2025.

Within clinical practice, these histologic criteria guide post-polypectomy surveillance and decisions regarding endoscopic versus surgical management. Pedunculated polyps with invasion confined to the head or stalk with no LVI or unfavorable histology may be considered low risk in some guidelines, while sessile polyps with deep invasion or adverse features demand more aggressive management Lim and Sohn DK. 2026.

Thus, the histologic criteria used to distinguish low-risk from high-risk colorectal polyps include:

• Lymphovascular invasion (presence indicates high risk)
• Poor histological differentiation (high grade)
• Depth of submucosal invasion (≥1,000 μm or sm2–3 level)
• Tumor budding (high-grade BD2 or BD3)
• Positive or indeterminate resection margins
• Polyp size ≥10 mm
• Villous or tubulovillous histology
• High-grade dysplasia
• Serrated lesions with dysplasia

The integration of these features into risk stratification frameworks allows tailored management balancing risk of progression against overtreatment. While international guidelines provide the consensus framework, emerging literature highlights biological heterogeneity, particularly in early-onset lesions and serrated pathways, underscoring the need for refined, potentially molecularly informed stratification models Akimoto et al. 2026,Baker et al. 2025,Lim and Sohn DK. 2026.